FDA allows AFT’s injectable iron project clinical study to proceed
AFT Pharmaceuticals has obtained positive FDA) approval to proceed with the next stage of its injectable iron research and development.
Market Cap $736.1M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.
